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Supplementary Figure 1
Supplementary Figure 1: Compatibility of BAG2 in the BRIL-GPCR chimera: Alignment of crystal 
structure of BRIL-BAG2 with crystal structures of different classes of GPCR with BRIL fusion either at the 
N-term or in the ICL3 position – (a) Dopamine D4 receptor (Class A) with N-term BRIL [PDB ID: 5WIU]. (b) 
Serotonin 5HT2B receptor (Class A) with ICL3 BRIL [PDB ID: 4IB4] (c) Glutamate receptor I (Class C) with 
ICL3 BRIL [PDB ID: 4OR2]. (d) A2A adenosine receptor (Class A) with ICL3 BRIL [PDB ID: 4EIY]. (e) 
Opioid N/OFQ receptor (Class A) with N-term BRIL [PDB ID: 4EA3]. (f) Serotonin 5HT2B receptor (Class A) 
with ICL3 BRIL [PDB ID: 5TUD]. In all cases, no potential clash was observed between the receptor 
and BAG2-BRIL structure.
Supplementary Figure 2
Supplementary Figure 2: Design and characterization of the YiiP-BRIL fusion constructs: (a) 
Two different loops – loop (residues 26-41, colored red) connecting helices 1 and 2 and loop 
(residues 158-179, colored blue) connecting helices 5 and 6 were tested for BRIL insertion. (b) 
Overlaid thermal melting curves of wt YiiP and the YiiP-BRIL fusion monitored by fluorescence using 
CPM probe.
Supplementary Figure 3
Supplementary Figure 3: BAG2 binding to different KcsA-BRIL fusion constructs: aSEC curves of 
the BRIL-KscA fusion constructs with different helical linkers without any sAB (red), with BAG2 (blue) and 
with a control sAB (green). In all constructs, 4 copies of BAG2 bind to the tetrameric assembly of KcsA as 
evident from the shift in the elution peak in comparison to that of the complex with control sAB. 2 copies of 
control sAB bind to each tetramer of KcsA (unpublished data).
Supplementary Figure 4
Supplementary Figure 4: Representative micrographs of sAB bound membrane protein targets: Negative 
stain micrographs of complex of (a) Serotonin 5HT1B receptor and sAB24. (b) YiiP-BRIL and BAG2. 
(c) BRIL-2turn-KcsA and BAG2. (d) CryoEM micrograph of BRIL-3turn-KcsA bound to BAG2. 
Supplementary Figure 5
Supplementary Figure 5: Design and characterization of α4β2 nAChR BRIL fusion constructs: (a) 
BRIL was inserted between the MX and M4 helices α4, with 4 residues added before the N-terminus of 
BRIL as a linker.  Seven constructs of α4-fusion were made by varying the fusion site after the C-
terminus of BRIL by 7 single residue deletions (-ER-560-564) into the C-terminus of α4. (b) BRIL was 
inserted between the MX and M4 helices in β2 adding, 8 residues before the N-terminus of BRIL as a 
linker.  Seven constructs of β2 were made by varying the fusion site after the C-terminus of BRIL by 7 
single residue deletions (421-427) into the C-terminus of β2.  (c) The BRIL fusion location in α4 
between MX and M4 helices is marked by an asterisk.  (d) Guava assay of 2 constructs representing α4 
and β2 BRIL fusions.  Expression of the receptor at the cell surface was detected using antibodies to 
the affinity tags on the subunits (top panel probed with anti-Strep antibody, bottom panel probed with 
anti-FLAG antibody).  The lower right quadrant in each plot is indicative of protein expression at the cell 
surface. BRIL insertion in α4 has higher expression (17%) compared to that in β2 (2%). (e) SDS-PAGE 
analysis of the fractions obtained from streptactin affinity chromatography purification of construct 8 with 
BRIL fusion α4 subunit, shows the β2 subunit band is denser, indicating that it is present in molar 
excess to α4 subunit.  This suggests that subunit stoichiometry is 2:3 (α4:β2). (f) SDS-PAGE analysis of 
the SEC fractions from the construct 8-sAB complex shows co-elution of the sAB with the receptor 
confirming the complex formation. The excess sAB used in the complex formation elutes later from the 
column. 
Supplementary Figure 6
Supplementary Figure 6: CryoEM data, 2D classification analyses and workflow of BRIL fused α4β2 
nAChR bound to BAK5: (a) Representative aligned sum of a movie of the receptor-sAB 
complex. Scale bar, 50 nm. (b) Selected 2D class averages from 1st round of 2D classification. The 
dimensions of the receptor and the receptor-sAB complex are shown. Arrows indicate the location of 
the sABs. (c) Selected 2D class averages of re-centered and re-extracted particles to refine the density of 
the BRIL andsAB regions. Arrows indicate the location of the sAB. A white circle outlines 
the diameter (350 Å) used for masking during 2D classification. (d) Strategy 1 - CryoEM data 
processing workflow focusing on the refinement of the α4β2 receptor only. Data processing procedure was 
implemented in relion-3.0-beta. The final map (blue box) has been sharpened and masked focusing on the 
α4β2 receptor.
Supplementary Figure 7
Supplementary Figure 7: CryoEM data processing workflow for improving the BRIL-BAK5 
region of the α4β2-BAG2 complex. Strategy 2 - Data processing procedure was implemented in 
relion-3.0-beta. The refined map (final) skipping focused 3D classification (blue box) has been 
sharpened and masked. Focused 3D classification was performed with mask on either α subunits 
including the BRIL and the sAB. The resulting post-processed maps with accompanying FSC curves 
are also shown. Close-up view of the BRIL-BAK5 interface is shown (green box).
Supplementary Figure 8
Supplementary Figure 8:  FSC Curves, angular distribution histogram and local resolution 
maps: FSC curves of the unmasked (red) and corrected masked (black) map with the indicated global 
resolution (a) at 3.7 Å (dotted) using Strategy 1 and (d) at 3.9 Å (dotted) using Strategy 2. Angular 
distribution histogram of the (b) refined map using Strategy 1 and (e) the final map using Strategy 2.  
Local resolution map (c) using Strategy 1 and (f) using Strategy 2 with the color keys in Å. The 
workflow using Strategy 1 and 2 have been detailed in Suppl. Fig. 6d and Suppl. Fig. 7 respectively. 
Supplementary Figure 9
Supplementary Figure 9: Superposition of  α4β2 nAChR with and without BRIL fusion: (a) Cryo-EM α4β2 
nAChR without BRIL fusion (PDB ID: 6CNJ, colored light pink) was superposed with the cryo-EM structure of 
the  α4β2 nAChR with BRIL fusion under study (PDB ID: 6USF, colored marine) with an RMSD Cα = 0.7Å. (b) 
Superposition of the β2 subunit. (c) Superposition of the α4 subunit. (d) Close-up view of the boxed part of (c). 
RMSD Cα upon superposition of the helices (6USF) into which BRIL was fused with that of 6CNJ was 0.3 Å 
(residues 278-306, numbering based on 6CNJ) and 0.5 Å (residues 355-370, numbering based on 6CNJ). The 
points of attachment of BRIL in between the helices are shown by black arrows.






sAB1	 6.0	X	104	 3.6	X	10-4	 6.0	
sAB2	 5.1	X	104	 9.4	X	10-5	 1.9	
sAB7	 4.7	X	105	 5.7	X	10-3	 12.2	
sAB10	 1.6	X	105	 2.0	X	10-3	 12.5	
sAB12	 1.6	X	105	 1.6	X	10-4	 1.0	
sAB18	 1.3	X	105	 1.9	X	10-3	 14.0	
sAB24	 3.4	X	104	 8.0	X	10-4	 23.0	
Supplementary Table 2: Kinetic parameters of the wild type (wt) and affinity matured variants of 
sAB24 determined by SPR 





wt	sAB24	 YLYYSLV	 FSSSSI	 YISSSSGSTS	 WGYWPGEPWWKAF	 3.4	X	104	 8.0	X	10-4	 23.0	nM	
BAG2	 VVDFSL	 4.9	X	105	 1.3	X	10-4	 269	pM	
BAK7	 VIGFTI	 4.2	X	105	 1.9	X	10-4	 446	pM	
BAK5	 VRSFSI	 7.8	X	105	 1.3	X	10-4	 175	pM	
BAG5	 ISEYTV	 6.3	X	105	 9.8	X	10-5	 155	pM	
CDR-L3, H2 and H3 sequences of the wt sAB24 and the affinity matured variants are identical. 







wt	sAB-24	 FSSSSI	 3.4	X	104	 8.0	X	10-4	 23.0	
BAG2	 VVDFSL	 4.9	X	105	 1.3	X	10-4	 0.3	
F35A	 VVDASL	 3.8	X	104	 2.8	X	10-4	 7.6	
S36A	 VVDFAL	 7.0	X	104	 3.7	X	10-4	 5.3	
Supplementary Table 4: Data collection and refinement statistics 
















































SupplementaryTable 6: (a) Design and (b) characterization of the different b-RIL-fused constructs of 
human α4β2 nAChR 
Supplementary Table 6(a) 








































1	 A	+	J	 None	 35.6	 NA	 NA	




4	 D	+	J	 18.2	 NA	 NA	
5	 E	+	J	 15.9	 NA	 NA	
6	 F	+	J	 16.8	 NA	 NA	
7	 G	+	J	 18.8	 NA	 NA	
8	 H	+	J	 19.7	 17	 Monodisperse	




11	 A	+	L	 19.2	 NA	 NA	
12	 A	+	M	 16.3	 NA	 NA	
13	 A	+	N	 24.5	 2	 Monodisperse	
14	 A	+	O	 18.8	 NA	 NA	
15	 A	+	P	 18.5	 NA	 NA	













































PDB ID	 6UR8	 6USF	
0.0 0.08
Outliers (%)
93.08	
0.0	
